Alventa
On the Bulgarian pack: Алвента 150 mg капсули с удължено освобождаване, твърди
150 mg prolonged-release capsules, hard · prolonged release capsules, hard
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Venlafaxine
- Made by
- KRKA, d.d. Novo Mesto
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (venlafaxine hydrochloride). It describes the substance, not this Bulgarian product — its uses and doses can differ.
The mechanism of action of venlafaxine in the treatment of MDD, GAD, SAD, and PD is unclear, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake.
Following absorption, venlafaxine undergoes extensive presystemic metabolism in the liver, primarily to ODV, but also to N-desmethylvenlafaxine, N,O-didesmethylvenlafaxine, and other minor metabolites.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-02
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (venlafaxine hydrochloride). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies.
- Hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate, or any excipients in the venlafaxine hydrochloride extended-release capsules formulation ( 4 ).
- Concomitant use of monoaminoxidase inhibitors (MAOIs) or within 14 days of discontinuing an MAOI ( 4, 5.2, 7.1 ).
The most common adverse reactions leading to discontinuation in ≥1% of the venlafaxine hydrochloride extended-release capsules treated patients in the short-term studies (up to 12 weeks) across indications are shown in Table 7.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States36 matching products
Spain41 matching products
- VANDRAL RETARD 150 mg venlafaxina hidrocloruro · cápsula dura de liberación prolongada3 makers
- ARAFAXINA RETARD 150 mg venlafaxina hidrocloruro · cápsula dura de liberación prolongada
- DISLAVEN RETARD 150 mg venlafaxina hidrocloruro · cápsula dura de liberación prolongada
- DOBUPAL RETARD 150 mg Venlafaxina · cápsula dura de liberación prolongada
- LEVEST RETARD 150 mg venlafaxina · cápsula dura de liberación prolongada
- VENLAFAXINA BLUEFISH 150 MG · cápsula dura de liberación prolongada
- VENLAFAXINA RETARD ALTER 150 mg venlafaxina hidrocloruro · cápsula dura de liberación prolongada
- VENLAFAXINA RETARD ALTER GENERICOS 150 mg venlafaxina hidrocloruro · cápsula dura de liberación prolongada
Canada19 matching products
- VENLAFAXINE XR 150 mg · capsule (extended-release)5 makers
- ACT VENLAFAXINE XR 150 mg · capsule (extended-release)
- APO-VENLAFAXINE XR 150 mg · capsule (extended-release)
- AURO-VENLAFAXINE XR 150 mg · capsule (extended-release)
- BIO-VENLAFAXINE XR 150 mg · capsule (extended-release)
- EFFEXOR XR 150 mg · capsule (extended-release)
- M-VENLAFAXINE XR 150 mg · capsule (extended-release)
- MAR-VENLAFAXINE XR 150 mg · capsule (extended-release)
Netherlands12 matching products
- Efexor XR 150 150 mg · capsule met verlengde afgifte, hard4 makers
- Venlafaxine retard Teva 150 mg 150 mg · capsule met verlengde afgifte, hard2 makers
- Venfalex XR 150 mg 150 mg · capsule met verlengde afgifte, hard
- Venlafaxine Aurobindo 150 mg 150 mg · capsule met verlengde afgifte, hard
- Venlafaxine HCl Retard Alembic 150 mg 150 mg · capsule met verlengde afgifte, hard
- Venlafaxine HCl Sandoz XR 150 mg 150 mg · capsule met verlengde afgifte, hard
- Venlafaxine retard Krka 150 mg 150 mg · capsule met verlengde afgifte, hard
- Venlafaxine Retard Viatris 150 mg 150 mg · capsule met verlengde afgifte, hard
SwitzerlandNo exact match for this strength and form
Details
| Made by | KRKA, d.d. Novo Mesto · Slovenia |
|---|---|
| Active substance | Venlafaxine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 150 mg prolonged-release capsules, hard |
| Form | prolonged release capsules, hard |
| Pack sizes | 10 · 14 · 20 · 28 · 30 · 50 · 98 · 100 · 250 |
| Classification | N06AX16 · Pain, sleep, mood, epilepsy and the brain |
| Name in the register | Алвента 150 mg капсули с удължено освобождаване, твърди |
| Reg. no. | 20080059 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- prolonged release capsules, hard4 products
- 75 mg prolonged-release capsules, hard
- 75 mg prolonged-release capsules, hard 100
- 150 mg prolonged-release capsules, hard
- 150 mg prolonged-release capsules, hard 100
- prolonged release capsule, hard2 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.